Enhanced Adverse-Event Detection and Drug-Event Relation Extraction from Clinical Notes

Area of Science:

• Biomedical Informatics
• Natural Language Processing
• Clinical Data Mining

Background:

• Adverse drug events (ADEs) represent a major cause of preventable patient harm.
• Identifying ADEs in free-text clinical notes is challenging due to the nuanced ways adverse events (AEs) and their reasons for treatment are described.
• Current entity extraction methods struggle to differentiate between ADEs and reasons for drug treatment, leading to relation classification errors.

Purpose of the Study:

• To develop and evaluate a two-stage framework for more accurate detection and classification of drug-event relationships in clinical text.
• To improve the distinction between adverse drug events (ADEs) and drugs administered as a reason for treating an adverse event.
• To enhance the performance of end-to-end pharmacovigilance systems.

Main Methods:

• Proposed a two-stage framework: first, detecting adverse events (AEs) as a unified category.
• Second, classifying drug-event pairs into Drug-ADE, Drug-Reason, or No-Relation categories.
• Evaluated the system on the N2C2 2018 benchmark dataset for end-to-end performance.

Main Results:

• Achieved high F1 scores: 0.93 for Drug-ADE and 0.94 for Drug-Reason.
• Significantly improved upon previous end-to-end benchmark results (0.48 for Drug-ADE, 0.59 for Drug-Reason).
• Demonstrated the effectiveness of unifying AE detection before relation classification.

Conclusions:

• The proposed two-stage framework offers a more precise task formulation for identifying drug-event relationships.
• Results support the development of AE-focused datasets independent of drug linkage for more robust pharmacovigilance.
• The findings pave the way for more reliable automated systems in drug safety monitoring.